Related references
Note: Only part of the references are listed.Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immunooncology
Dong-Yi Chen et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G. Curigliano et al.
ANNALS OF ONCOLOGY (2020)
Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
Nicolas Palaskas et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
Agapios Sachinidis
CELLS (2020)
Pharmacogenomics for immunotherapy and immune-related cardiotoxicity
Jessica A. Castrillon et al.
HUMAN MOLECULAR GENETICS (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction
Wenzheng Xia et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
hiPSCs in cardio-oncology: deciphering the genomics
Emily A. Pinheiro et al.
CARDIOVASCULAR RESEARCH (2019)
Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell
Nazish Sayed et al.
CARDIOVASCULAR RESEARCH (2019)
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
Tomoya Kitani et al.
CIRCULATION (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients
Thomas D. Ryan et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Identification and Management of Immune Checkpoint Inhibitor-Related Myocarditis: Use Troponin Wisely
Paolo Spallarossa et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
Carlo Gabriele Tocchetti et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing
Gary Gintant et al.
CIRCULATION RESEARCH (2019)
Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
Yu-Wen Zhou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Pericardial effusion under nivolumab: case-reports and review of the literature
Anastasia Saade et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
Katsiaryna Marhelava et al.
CANCERS (2019)
Immunotherapy transforms cancer treatment
Neeha Zaidi et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan et al.
VIRCHOWS ARCHIV (2019)
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
Steven Feins et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
Nikhil Agrawal et al.
CASE REPORTS IN ONCOLOGY (2019)
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity
Lori M. Minasian et al.
JACC: CARDIOONCOLOGY (2019)
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
Gilda Varricchi et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases
Umbreen Hafeez et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy
Azadeh Tajmir-Riahi et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin
Varun Jain et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Immune checkpoint inhibitors and cardiovascular toxicity
Alexander R. Lyon et al.
LANCET ONCOLOGY (2018)
Cardio-oncology: an overview on outpatient management and future developments
A. J. Teske et al.
NETHERLANDS HEART JOURNAL (2018)
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
Daniel Y. Wang et al.
JAMA ONCOLOGY (2018)
Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity
Arun Sharma et al.
NATURE PROTOCOLS (2018)
Cardiotoxicity of Anticancer Therapeutics
Jerry Dong et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
An anti-EGFR x cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations
Junyeong Jin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Guoqing Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling
Mario Niepel et al.
NATURE COMMUNICATIONS (2017)
Risk of Heart Failure With Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer
Hirofumi Saiki et al.
CIRCULATION (2017)
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes
Brian M. Necela et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
CD28/B7 Deficiency Attenuates Systolic Overload-Induced Congestive Heart Failure, Myocardial and Pulmonary Inflammation, and Activated T Cell Accumulation in the Heart and Lungs
Huan Wang et al.
HYPERTENSION (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Evaluation and Treatment of Pericarditis A Systematic Review
Massimo Imazio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The application of monoclonal antibodies in cancer diagnosis
Xuemei Zhang et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
G. Curigliano et al.
ANNALS OF ONCOLOGY (2012)
Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule
Yongjing Chen et al.
HYBRIDOMA (2010)
Therapeutic applications of monoclonal antibodies
M Berger et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2002)
Share Paper
